Cannabix Technologies Presents FAIMS Marijuana Breathalyzer Technology at the Texas Impaired Driving Forum
UF startup Cannabix Technologies Inc., presented key innovations for first-of-its-kind marijuana breath detection technology. This comes at a time when legislators are grappling with the ever-increasing problem of drugged driving.
GrowFL Announces Lacerta Therapeutics as an Honoree: 11th Annual Florida Companies to Watch
Lacerta Therapeutics is pleased to be among the top 50 second-stage companies in Florida selected as an 11th Annual GrowFL Florida Companies to Watch honoree, a statewide competition that identifies companies expected to see significant growth over the next several years.
Fitness App FitOn Raises $40M, Acquires Corporate Wellness Platform Peerfit
Digital fitness and wellness company FitOn has raised $40 million in Series C funding led by Delta-v Capital, the company announced on Tuesday. FitOn is also expanding its reach in wellness by acquiring Tampa-based corporate wellness platform Peerfit, a UF startup that incubated at UF Innovate | Accelerate at The Hub.
Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment
The U.S. Department of Defense (DOD) has awarded UF startup Ology Bioservices, Inc. (Ology), a wholly-owned subsidiary of Resilience, a contract valued as much as $250 million for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxins (BoNT).
TearClear Announces Initiation of TC-002 Latanoprost Ophthalmic Solution Phase 3 Trial
TearClear has announced the TC-002 phase 3 trial has been successfully initiated. TearClear’s phase 3 trial (CLEAR Study) is a prospective, double-masked, randomized, multicenter, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive efficacy of TC-002 ophthalmic solution (TearClear Preservative-Free Latanoprost Ophthalmic Solution 0.005%) compared to marketed Latanoprost ophthalmic solution 0.005%.
UF Health Researchers Develop App To Help Monitor New Moms for Postpartum Complications
UF researcher Kay Roussos-Ross and colleagues developed a smartphone app called Gator MOMitor™ that new mothers can use to report worrying symptoms in the early weeks after giving birth. UF Health follows up with a phone call if someone reports a problem.
Meet Alex Makes Cancer Screenings More Accessible
Dr. Janice Krieger and Mohan Zalake developed Meet Alex, a virtual clinician created to encourage patients in minority populations to get screened for colorectal cancer.
AGTC-501 Gene Therapy Offers Vision Gains for X-Linked RP
AGTC-501 (Applied Genetic Technologies Corporation), a novel gene therapy in development for the potential treatment of X-linked retinitis pigmentosa (RP), showed an acceptable safety profile and visual function improvements when administered in the study’s higher dose groups, according to Robert A. Sisk, MD, FACS, from the Cincinnati Eye Institute in Ohio.
NAU Country Signs Deal with Agriculture Intelligence for Agroview, the Next Innovation for Crop Insurance
Agriculture Intelligence, a precision agriculture-science company combining automation, remote sensing and artificial intelligence to provide cloud-based, precision data for specialty crops, has announced a multi-year partnership with NAU Country for its award-winning AI platform Agroview.
Surgalign Receives FDA Clearance for Surgical Guidance System
Surgalign Holdings Inc. said Tuesday it has received initial U.S. Food & Drug Administration clearance for its HOLO Portal surgical guidance system for use within lumbar spine procedures.
